EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+14.76%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$2.1B
AUM Growth
+$2.1B
(+0.21%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-8.85%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
429
New
31
Increased
85
Reduced
265
Closed
35
Top Buys
| 1 |
abrdn Physical Gold Shares ETF
SGOL
|
$20M |
| 2 |
iShares Gold Trust
IAU
|
$19.8M |
| 3 |
SPDR Gold MiniShares Trust
GLDM
|
$19.6M |
| 4 |
SPDR Gold Trust
GLD
|
$19.6M |
| 5 |
Invesco DB Oil Fund
DBO
|
$11M |
Top Sells
| 1 |
KE Holdings
BEKE
|
$70.4M |
| 2 |
Futu Holdings
FUTU
|
$37.4M |
| 3 |
Apple
AAPL
|
$18.8M |
| 4 |
Microsoft
MSFT
|
$13.6M |
| 5 |
Applied Materials
AMAT
|
$11.3M |
Sector Composition
| 1 | Technology | 43.87% |
| 2 | Consumer Discretionary | 23.94% |
| 3 | Communication Services | 11.36% |
| 4 | Healthcare | 5.11% |
| 5 | Financials | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
GE HealthCare
GEHC
$32.7B
| $1.14M | 0.05% |
15,403
-910
| -6% | -$67.4K |
|
152
Rubrik
RBRK
$17B
| $1.14M | 0.05% |
+12,720
| New | +$1.14M |
|
153
Verisk Analytics
VRSK
$37B
| $1.14M | 0.05% |
3,658
-319
| -8% | -$99.4K |
|
154
Exelon
EXC
$43.8B
| $1.13M | 0.05% |
26,066
-2,114
| -8% | -$91.8K |
|
155
Tapestry
TPR
$21.4B
| $1.12M | 0.05% |
12,744
| – | – |
|
156
United Therapeutics
UTHR
$18.3B
| $1.12M | 0.05% |
3,881
+591
| +18% | +$170K |
|
157
Interactive Brokers
IBKR
$28.5B
| $1.11M | 0.05% |
20,000
+18,000
| +900% | +$997K |
|
158
Insmed
INSM
$30.7B
| $1.1M | 0.05% |
10,951
-2,692
| -20% | -$271K |
|
159
Natera
NTRA
$23.2B
| $1.09M | 0.05% |
6,435
-556
| -8% | -$93.9K |
|
160
Neurocrine Biosciences
NBIX
$14.1B
| $1.09M | 0.05% |
8,642
-620
| -7% | -$77.9K |
|
161
Ross Stores
ROST
$49.5B
| $1.08M | 0.05% |
8,485
-752
| -8% | -$95.9K |
|
162
Coinbase
COIN
$78B
| $1.08M | 0.05% |
+3,071
| New | +$1.08M |
|
163
Johnson Controls International
JCI
$69.3B
| $1.04M | 0.05% |
+9,824
| New | +$1.04M |
|
164
Halozyme
HALO
$8.58B
| $1.04M | 0.05% |
19,926
+9,542
| +92% | +$496K |
|
165
Celsius Holdings
CELH
$15.8B
| $1.03M | 0.05% |
+22,305
| New | +$1.03M |
|
166
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.03M | 0.05% |
18,772
+6,534
| +53% | +$359K |
|
167
Electronic Arts
EA
$42.9B
| $1.03M | 0.05% |
6,426
-869
| -12% | -$139K |
|
168
Exact Sciences
EXAS
$9.09B
| $1.02M | 0.05% |
19,278
-2,515
| -12% | -$134K |
|
169
Xcel Energy
XEL
$42.7B
| $1.02M | 0.05% |
14,975
-1,354
| -8% | -$92.2K |
|
170
Diamondback Energy
FANG
$43.4B
| $1M | 0.05% |
7,307
-574
| -7% | -$78.9K |
|
171
Coca-Cola Europacific Partners
CCEP
$39.7B
| $997K | 0.05% |
10,751
-856
| -7% | -$79.4K |
|
172
Baker Hughes
BKR
$44.7B
| $986K | 0.05% |
25,727
-2,165
| -8% | -$83K |
|
173
CDW
CDW
$21.3B
| $976K | 0.05% |
5,467
-578
| -10% | -$103K |
|
174
AstraZeneca
AZN
$249B
| $970K | 0.05% |
13,887
-967
| -7% | -$67.6K |
|
175
BridgeBio Pharma
BBIO
$9.56B
| $948K | 0.05% |
21,965
+3,075
| +16% | +$133K |
|